Skip to main content
. 2022 Oct 31;38(5):1499–1511. doi: 10.1007/s00467-022-05762-4

Fig. 1.

Fig. 1

Selection of non-IIS sample from PodoNet SRNS cohort. SRNS, steroid-resistant nephrotic syndrome; CNI, calcineurin inhibitor; CPH, cyclophosphamide; IIS, intensified immunosuppressive treatment; MMF, mycophenolate mofetil; non-IIS, children not treated with intensified immunosuppression; RAAS, renin–angiotensin–aldosterone antagonist